Risk Factors of Fatal Outcome in Patients With COVID-19 Pneumonia.


Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 11 9 2020
medline: 26 5 2022
entrez: 10 9 2020
Statut: ppublish

Résumé

The aim of this study was to correlate the clinical, laboratory, and radiographic characteristics of patients with a confirmed diagnosis of coronavirus disease 2019 (COVID-19) disease, with fatal outcome. We reviewed chest X-ray (CXR) features, clinical, and laboratory data of patients with reverse transcriptase polymerase-chain-reaction confirmed diagnosis of COVID-19 infection. The relationship with mortality was investigated by fitting a logistic regression model. A total of 246 patients were included (170 males; mean age, 63 y). Most of the patients had 1 or more comorbidity (62%); fever (95%), and cough (60%) were the most common symptoms; CXR detected abnormalities in 88.6%, mainly showing ground-glass opacities (GGO) (90%) with bilateral (64%) and peripheral (46%) distribution.Multivariate analysis showed that age (P < 0.001; mortality of 59% in patients >66 y old; 5% at a younger age) and consolidation at CXR (P = 0.001; mortality of 11% with positive CXR; 2% in those without) represented the 2 most significant independent risk factors of mortality. Chronic pathologies, such as diabetes and chronic obstructive pulmonary disease, and peripheral GGO at CXR also showed a significant correlation with mortality. We identified predictive factors for the fatal outcome of COVID-19 patients. The prognostic value of these findings can be useful for optimal patient management and resource allocation.

Identifiants

pubmed: 32907676
pii: S1935789320003468
doi: 10.1017/dmp.2020.346
pmc: PMC7653489
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271-278

Auteurs

Michaela Cellina (M)

Department of Radiology, ASST Fatebenefratelli Sacco, Milano, Italy.

Daniele Gibelli (D)

Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milano, Italy.

Carlo Valenti Pittino (C)

Scuola di Specializzazione in Radiodiagnostica, Università degli Studi di Milano, Milano, Italy.

Tahereh Toluian (T)

Scuola di Specializzazione in Radiodiagnostica, Università degli Studi di Milano, Milano, Italy.

Pietro Marino (P)

Department of Emergency Medicine, ASST Fatebenefratelli Sacco, Milano, Italy.

Giancarlo Oliva (G)

Department of Radiology, ASST Fatebenefratelli Sacco, Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH